Scarica l'app Stockscreener
29.71
2.04%
-0.62
Dopo l'orario di chiusura:
29.26
-0.45
-1.51%
Precedente Chiudi:
$30.33
Aprire:
$29.75
Volume 24 ore:
1.86M
Relative Volume:
0.44
Capitalizzazione di mercato:
$1.89B
Reddito:
$14.34M
Utile/perdita netta:
$-199.00M
Rapporto P/E:
-7.5791
EPS:
-3.92
Flusso di cassa netto:
$-183.51M
1 W Prestazione:
-3.66%
1M Prestazione:
-48.78%
6M Prestazione:
+116.86%
1 anno Prestazione:
+380.74%
Intervallo 1D:
$28.42
$30.62
Intervallo di 1 settimana:
$28.29
$31.38
Portata 52W:
$5.50
$71.50
Uniqure N V Stock (QURE) Company Profile
Nome
Uniqure N V
Settore
Industria
Telefono
1-339-970-7000
Indirizzo
PAASHEUVELWEG 25A, AMSTERDAM
Confronta QURE con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
QURE
Uniqure N V
|
29.71 | 1.89B | 14.34M | -199.00M | -183.51M | -3.92 |
|
ARGX
Argen X Se Adr
|
918.53 | 57.24B | 3.06B | 1.28B | 447.35M | 19.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
435.52 | 110.12B | 11.74B | 3.68B | 3.34B | 14.19 |
|
INSM
Insmed Inc
|
201.62 | 42.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
|
ONC
Beone Medicines Ltd Adr
|
363.92 | 41.68B | 4.98B | 69.59M | 525.67M | 0.5197 |
|
REGN
Regeneron Pharmaceuticals Inc
|
725.34 | 74.02B | 14.25B | 4.58B | 3.88B | 41.77 |
Uniqure N V Stock (QURE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-04 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2025-08-14 | Aggiornamento | Mizuho | Neutral → Outperform |
| 2025-04-01 | Ripresa | Chardan Capital Markets | Buy |
| 2024-12-10 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2024-10-10 | Ripresa | Raymond James | Outperform |
| 2024-02-29 | Downgrade | Goldman | Buy → Neutral |
| 2023-12-19 | Downgrade | Mizuho | Buy → Neutral |
| 2022-03-17 | Aggiornamento | UBS | Neutral → Buy |
| 2021-06-15 | Iniziato | BTIG Research | Buy |
| 2021-05-21 | Iniziato | UBS | Neutral |
| 2021-04-26 | Ripresa | Credit Suisse | Outperform |
| 2021-04-01 | Aggiornamento | Mizuho | Neutral → Buy |
| 2021-01-07 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2020-11-24 | Iniziato | H.C. Wainwright | Buy |
| 2020-11-11 | Iniziato | Berenberg | Buy |
| 2020-11-09 | Iniziato | Jefferies | Buy |
| 2020-11-04 | Iniziato | Cantor Fitzgerald | Overweight |
| 2020-10-23 | Iniziato | RBC Capital Mkts | Outperform |
| 2020-08-25 | Iniziato | Raymond James | Strong Buy |
| 2020-07-31 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2020-06-25 | Downgrade | Mizuho | Buy → Neutral |
| 2020-06-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2020-06-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2019-12-03 | Iniziato | Cowen | Outperform |
| 2019-12-03 | Iniziato | Goldman | Buy |
| 2019-11-05 | Iniziato | Credit Suisse | Outperform |
| 2019-10-11 | Iniziato | Stifel | Buy |
| 2019-09-25 | Iniziato | Bernstein | Outperform |
| 2019-09-12 | Iniziato | Mizuho | Buy |
| 2019-07-30 | Downgrade | Guggenheim | Buy → Neutral |
| 2019-07-08 | Reiterato | Cantor Fitzgerald | Overweight |
| 2019-04-12 | Iniziato | Piper Jaffray | Overweight |
| 2019-03-29 | Iniziato | Robert W. Baird | Outperform |
Mostra tutto
Uniqure N V Borsa (QURE) Ultime notizie
Is uniQure N.V. stock a buy on dips2025 Dividend Review & Daily Chart Pattern Signal Reports - newser.com
Do Rising Losses at uniQure (QURE) Reflect Strategic Investment or Escalating Cost Pressure? - simplywall.st
Why uniQure N.V. (UQ1) stock is trending on social media2025 Bull vs Bear & Verified Entry Point Detection - newser.com
Will uniQure N.V. stock deliver shareholder valueSell Signal & Free Safe Entry Trade Signal Reports - newser.com
Is uniQure N.V. (UQ1) stock supported by strong fundamentalsExit Point & AI Enhanced Trading Alerts - newser.com
How currency fluctuations impact uniQure N.V. stockMarket Sentiment Report & Real-Time Volume Analysis - newser.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating uniQure N.V. (QURE) And Encourages Shareholders to Connect - ACCESS Newswire
Wall Street Has a Positive Outlook on uniQure N.V. (QURE) Despite Challenges From The FDA - Insider Monkey
Predicting uniQure N.V. trend using moving averagesProduct Launch & Low Drawdown Momentum Trade Ideas - newser.com
What data driven models say about uniQure N.V.’s futureQuarterly Trade Report & Expert Verified Stock Movement Alerts - newser.com
Can uniQure N.V. (UQ1) stock sustain revenue momentumPortfolio Return Summary & Weekly Stock Breakout Alerts - newser.com
Volatility clustering patterns for uniQure N.V.Weekly Stock Report & High Accuracy Swing Entry Alerts - newser.com
How to read the order book for uniQure N.V.2025 Buyback Activity & Safe Capital Growth Stock Tips - newser.com
Risk adjusted return profile for uniQure N.V. analyzedJuly 2025 Sector Moves & Stepwise Trade Execution Plans - newser.com
uniQure N.V. Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors With Significant Losses to Contact the Firm - FinancialContent
uniQure NV Hits Day High with 15.18% Surge Amid Market Volatility - Markets Mojo
uniQure N.V. (NASDAQ:QURE) Analysts Just Slashed Next Year's Revenue Estimates By 26% - Yahoo Finance
Can uniQure N.V. stock hit analyst price targetsJuly 2025 Selloffs & Verified Momentum Stock Ideas - newser.com
UniQure N.V. Investigated for Securities Fraud ViolationsContact the DJS Law Group to Discuss Your RightsQURE - 富途牛牛
10 Health Care Stocks With Whale Alerts In Today's Session - Benzinga
How institutional buying supports uniQure N.V. stock2025 Trading Volume Trends & Real-Time Market Sentiment Alerts - newser.com
What catalysts could drive uniQure N.V. stock higherJuly 2025 Institutional & Scalable Portfolio Growth Methods - newser.com
Why uniQure N.V. stock is rated strong buyWeekly Gains Report & Verified Entry Point Detection - Fundação Cultural do Pará
NASDAQ: QURE Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors With Significant Losses to Contact the Firm - NewMediaWire
FDA Unveils New Path for Approving Rare Disease Drugs for Just One Person - Bloomberg.com
Makary, Prasad outline pathway for bespoke gene therapy - statnews.com
Uniqure’s CEO dined with investors. Here’s what he said - statnews.com
Analysts Have Lowered Expectations For uniQure N.V. (NASDAQ:QURE) After Its Latest Results - Yahoo Finance
NASDAQ: QURE Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors With Significant Losses to Contact the Firm - NewMediaWire
Bronstein, Gewirtz & Grossman, LLC Is Investigating uniQure N.V. (QURE) And Encourages Investors to Connect - ACCESS Newswire
uniQure (QURE): Wells Fargo Adjusts Price Target to $60, Maintai - GuruFocus
Can uniQure N.V. stock hit record highs againJuly 2025 Selloffs & Short-Term High Return Ideas - newser.com
QURE Investors Have Opportunity to Join uniQure N.V. Fraud Investigation with the Schall Law Firm - GlobeNewswire
H.C. Wainwright Maintains UniQure NV(QURE.US) With Buy Rating, Maintains Target Price $70 - 富途牛牛
Wells Fargo Maintains UniQure NV(QURE.US) With Buy Rating, Cuts Target Price to $60 - 富途牛牛
uniQure NV Hits Day High with 17.93% Surge Amid Strong Intraday Performance - Markets Mojo
uniQure (QURE) Surges 17.9% Ahead of 2 Health Conferences - Insider Monkey
A Quick Look at Today's Ratings for UniQure NV(QURE.US), With a Forecast Between $45 to $60 - 富途牛牛
Liquidity Mapping Around (QURE) Price Events - news.stocktradersdaily.com
uniQURE N.V. Investigation: Investors Encouraged to Contact Kirby McInerney LLP - The AI Journal
uniQure’s Bumpy Ride: Stock Price Prospects - timothysykes.com
Bronstein, Gewirtz & Grossman, LLC Encourages uniQure N.V. (QURE) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Uniqure N V Azioni (QURE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.08%
0.19%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):